Aptamer Group plc (AIM: APTA)

https://www.aptamergroup.com

Aptamer Group develops custom affinity binders through its proprietary Optimer® platform to enable new approaches in therapeutics, diagnostics and research applications. The Company strives to deliver transformational solutions that meet the needs of life science researchers and developers through the use of its proprietary Optimer platform. Optimer binders are oligonucleotide affinity ligands that can function as an antibody alternative. The global antibody market is currently worth over $145bn. Optimer binders are engineered to address many of the issues found with alternative affinity molecules, such as antibodies, and offer new, innovative solutions to bioprocessing, diagnostic and pharmaceutical scientists. Aptamer Group has successfully delivered projects for global pharma companies, diagnostic development companies, and research institutes covering a range of targets and applications with the objective of establishing royalty-bearing licenses. Through the unique Optimer technology and processes, scientists and collaborators are enabled to make faster, more informed decisions that support discovery and development across the Life Sciences. *

	Start	2021-12-08 reorganised
	Group	Aptamer Group (Group)
	Predecessor	Aptamer Group Ltd.
	Industry	aptamer drug conjugate (ApDC)
	Person	Tolley, Arron (Aptamer Group 2008– CEO + Co-Founder)
	Person 2	Courtman-Stock, Eleanor (Aptamer Group 202112 CFO)

	Region	Heslington, North Yorkshire
	Country	United Kingdom (GB)
	Street	Innovation Way
	City	YO10 5NY Heslington, York
		Address record changed: 2024-01-05

Basic data	Employees	B: 11 to 50 (2021-12-20)

		* Document for »About Section«: Aptamer Group plc. (12/22/21). "Press Release: Admission to Trading on AIM and First Day of Dealings [Not for US, CA, AU, JP, et al.]".

		Record changed: 2025-03-16

Picture EBD Group Asia Bio Partnering Forum 2026 Singapore 650x200px

More documents for Aptamer Group (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)